THOMPSON DAVIS & CO., INC. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$39,000
-7.1%
5,0000.0%0.06%
-6.8%
Q3 2015$42,000
-23.6%
5,0000.0%0.06%
-6.3%
Q2 2015$55,000
+31.0%
5,000
+66.7%
0.06%
+26.0%
Q1 2015$42,000
-17.6%
3,0000.0%0.05%
-15.3%
Q4 2014$51,0003,0000.06%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders